Pomegra
CVS Stock Rises 1.2% After Hours on Pharmacy Spin-Off Report
Why did CVS stock rise after the pharmacy spin-off report?
CVS Health (CVS) stock rose 1.2% to $92.50 in after-hours trading on Tuesday after reports said it will spin off its retail pharmacies by the first half of 2028.
Key numbers
| CVS close, Nov 3 | $91.41+3.28% |
|---|---|
| After-hours move | $92.50+1.2% (per [2]) |
| Retail drugstores to be spun off | ~9,000 |
| Annual revenue | $417Bretail ~1/3 |
| CVS year to date | +15%through Nov 3 close |
What happened
CVS Health (CVS) stock rose 1.2% to $92.50 in after-hours trading on Tuesday after reports said it will spin off its retail pharmacies by the first half of 2028. About 9,000 drugstores, mail-order pharmacy and MinuteClinic sites would form a new company, CVS Pharmacy, while insurer Aetna and drug-benefit manager Caremark stay together. Shares had already closed up 3.28% at $91.41 before the news, and reports differ on the after-hours move, from 0.1% to as much as 3.7%. CVS reports quarterly results Wednesday, when it could confirm the plan.
Why it matters
CVS Health is one of America's biggest healthcare companies, and splitting off its drugstores would undo its $78 billion purchase of insurer Aetna in 2018. The drugstore arm brings in about a third of the company's $417 billion in yearly sales. The move comes as lawmakers press to separate drug-benefit managers from pharmacies and insurers, which could change how prescriptions are priced and sold.
Who this affects
- MarketbullishLow impact
- Healthcare investors get two simpler stocks; early reaction positive.
- CompanymixedHigh impact
- CVS shareholders gain two focused companies but lose some synergies.
- CompetitorsneutralLow impact
- Rival insurers and drugstore chains face two more focused competitors.
- IndustrymixedMedium impact
- Could ease political pressure to separate drug-benefit managers from pharmacies.
CVS Health vs UnitedHealth, Cigna, Humana
How we got here
CVS completes its roughly $78 billion purchase of insurer Aetna.
FT and WSJ report CVS plans to spin off its retail pharmacies.
CVS closes up 3.28% at $91.41, then edges higher after hours.
CVS due to report quarterly results, when it could confirm the plan.
What to watch
- Whether CVS confirms the split and its timeline in quarterly results2026-11-04
- Details on leadership, financing and structure of the new CVS Pharmacy company2026-11-04
- Completion of the separation, expected in the first half of 2028H1 2028
Educational content only. Not investment advice.
More briefsAll briefs →
Regeneron Stock Jumps 13% After Record Q3 Earnings
Regeneron (REGN) hit a 52-week high as Sanofi expanded their alliance, worth up to $8B, and earnings rose 70%.
Oil Falls 1.1% on Iran Peace Talk Hopes
Brent crude (BZ=F) fell for a second day, the S&P 500 rose 0.4%, and Trump said US aid to Israel will end.
Palantir Stock Falls 1.7% on Q3 Earnings as Contract Growth Slows
Palantir (PLTR) beat revenue estimates with sales up 96%, but slower new-contract growth worried investors.